The action mechanism of cinobufagin for the treatment of mouse hind paw cancer pain was mainly related to improving the level of peripheral β-END and the role of peripheral opioid receptors; however, the synthesis of β-END is complex [27], and the mechanism by which signaling pathways improve the synthesis and release of β-END is unclear. The gene discussed is ENG; the disease is cancer.